Promoted for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Posted
Kronos Bio, Inc is an other business based in the US. Kronos Bio shares (KRON.US) are listed on the NASDAQ and all prices are listed in US Dollars. Kronos Bio employs 61 staff and has a market cap (total outstanding shares value) of $1.8 billion.
Promoted for
Beginners
Promoted for
Advanced Traders
Promoted for
Trading UX
Latest market close | $N/A |
---|---|
52-week range | $25.5006 - $39.605 |
50-day moving average | $32.0019 |
200-day moving average | $31.3357 |
Wall St. target price | $43.67 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | N/A |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Gross profit TTM | USD$0 |
---|---|
Return on assets TTM | 0% |
Return on equity TTM | 0% |
Profit margin | 0% |
Book value | N/A |
Market capitalisation | USD$1.8 billion |
TTM: trailing 12 months
There are currently 2.0 million Kronos Bio shares held short by investors – that's known as Kronos Bio's "short interest". This figure is 53.3% up from 1.3 million last month.
There are a few different ways that this level of interest in shorting Kronos Bio shares can be evaluated.
Kronos Bio's "short interest ratio" (SIR) is the quantity of Kronos Bio shares currently shorted divided by the average quantity of Kronos Bio shares traded daily (recently around 293711.634757). Kronos Bio's SIR currently stands at 6.79. In other words for every 100,000 Kronos Bio shares traded daily on the market, roughly 6790 shares are currently held short.
However Kronos Bio's short interest can also be evaluated against the total number of Kronos Bio shares, or, against the total number of tradable Kronos Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Kronos Bio's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Kronos Bio shares in existence, roughly 40 shares are currently held short) or 0.0515% of the tradable shares (for every 100,000 tradable Kronos Bio shares, roughly 52 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Kronos Bio.
Find out more about how you can short Kronos Bio stock.
We're not expecting Kronos Bio to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib, a selective inhibitor targeting spleen tyrosine kinase in acute myeloid leukemia patients. The company is also developing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9 for the treatment of MYC-amplified solid tumors. Kronos Bio, Inc. is founded in 2017 and is headquartered in San Mateo, California.
Steps to owning and managing 17 Education & Technology Group stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing StealthGas stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Enterprise Products stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing DXC stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Bionano Genomics stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Sunrun stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing PLDT stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Oxford Lane Capital stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing NetEase stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Gulfport Energy stocks, with 24-hour and historical pricing before you buy.